興科蓉醫藥：年報2021.pdf

1、ANNUAL REPORT?Contents 目錄2Corporate Information公司資料4Financial Highlights財務摘要6Chairman s Statement主席報告10Management Discussion and Analysis管理層討論及分析29Environmental,Social and Governance Report環境、社會及管治報告55Directors and Senior Management董事及高級管理層61Report of the Directors董事會報告74Corporate Governance Report企

2、業管治報告96Independent Auditor s Report獨立核數師報告102Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表103Consolidated Statement of Financial Position綜合財務狀況表105Consolidated Statement of Changes in Equity綜合權益變動表106Consolidated Statement of Cash Flows綜合現金流量表109Notes to Financi

3、al Statements財務報表附註206Definitions釋義2Sinco Pharmaceuticals Holdings LimitedAnnual Report 2021Corporate Information公司資料BOARD OF DIRECTORExecutive DirectorsMr.Huang Xiangbin(Chairman and Co-Chief Executive Officer)Ms.Zhang Zhijie(resigned on 8 January 2021)Independent Non-executive DirectorsMr.Lau Ying

4、 KitMr.Liu WenfangMr.Wang QingMr.Bai ZhizhongAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai ZhizhongREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Mr.Liu WenfangMr.Bai Zhizhong(appointed on 8 January 2021)Ms.Zhang Zhijie(resigned on 8 January 2021)NOMINATION COMMITTEEMr.Huang

5、Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai ZhizhongAUTHORISED REPRESENTATIVESMr.Huang XiangbinMs.Li Kin Wai(appointed on 31 March 2021)Ms.Li Ching Yi(resigned on 22 January 2021)Ms.Wong Y

6、ik Han(appointed on 22 January 2021 and resigned on 31 March 2021)JOINT COMPANY SECRETARIESMs.Peng YunluMr.Li Kin Wai(appointed on 31 March 2021)Ms.Li Ching Yi(resigned on 22 January 2021)Ms.Wong Yik Han(appointed on 22 January 2021 and resigned on 31 March 2021)REGISTERED OFFICEPO Box 309Ugland Hou